Rotigotine transdermal system for the treatment of Parkinson's disease.

Rotigotine transdermal system for the treatment of Parkinson's disease.

Item
http://www.wikidata.org/entity/Q37191870
Rotigotine effects on early morning motor function and sleep in Parkinson's disease: a double-blind, randomized, placebo-controlled study (RECOVER).Rotigotine transdermal system for long-term treatment of patients with advanced Parkinson's disease: results of two open-label extension studies, CLEOPATRA-PD and PREFER.A review of ropinirole prolonged release in Parkinson's disease.Therapeutic options for continuous dopaminergic stimulation in Parkinson's diseaseEffects of rotigotine on Parkinson's disease-related sleep disturbances.Rotigotine transdermal system: developing continuous dopaminergic delivery to treat Parkinson's disease and restless legs syndrome.A review of adverse events linked to dopamine agonists in the treatment of Parkinson's disease.Recent trends in the transdermal delivery of therapeutic agents used for the management of neurodegenerative diseases.Design of phosphorus ligands with deep chiral pockets: practical synthesis of chiral β-arylamines by asymmetric hydrogenation.Phosphite-Thiother Ligands Derived from Carbohydrates allow the Enantioswitchable Hydrogenation of Cyclic β-Enamides by using either Rh or Ir Catalysts.
P2860

Rotigotine transdermal system for the treatment of Parkinson's disease.

Item
http://www.wikidata.org/entity/Q37191870
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Rotigotine transdermal system for the treatment of Parkinson's disease.
@en
Rotigotine transdermal system for the treatment of Parkinson's disease.
@nl
type
label
Rotigotine transdermal system for the treatment of Parkinson's disease.
@en
Rotigotine transdermal system for the treatment of Parkinson's disease.
@nl
prefLabel
Rotigotine transdermal system for the treatment of Parkinson's disease.
@en
Rotigotine transdermal system for the treatment of Parkinson's disease.
@nl
P1433
P1476
P304
P31
P356
P4011
P407
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Rotigotine transdermal system for the treatment of Parkinson's disease.
@en
P304
P31
P356
10.1016/J.CLINTHERA.2008.05.007
P4011
7683f30f7e27461b549230a86c7c947da6bbd343
P407
P433
P478
P50
P577
P698
P921